S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

iShares iBonds Dec 2030 Term Treasury ETF (IBTK) Price, Holdings, & News

$19.30
+0.07 (+0.36%)
(As of 11/29/2023 ET)
Compare
Today's Range
$19.27
$19.33
50-Day Range
$18.46
$19.30
52-Week Range
$18.45
$20.52
Volume
138,999 shs
Average Volume
70,509 shs
Market Capitalization
$157.30 million
Assets Under Management
$162.38 million
Dividend Yield
2.85%
Net Expense Ratio
0.07%
IBTK stock logo

About iShares iBonds Dec 2030 Term Treasury ETF (NASDAQ:IBTK)

The iShares iBonds Dec 2030 Term Treasury ETF (IBTK) is an exchange-traded fund that is based on the ICE 2030 Maturity US Treasury index. The fund tracks a market value-weighted index of US Treasury bonds maturing between January and December 2030. The fund will terminate in December 2030. IBTK was launched on Jul 14, 2020 and is managed by BlackRock.

IBTK Stock Price History

IBTK ETF News Headlines

IBDV iShares iBonds Dec 2030 Term Corporate ETF
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
See More Headlines
Receive IBTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares iBonds Dec 2030 Term Treasury ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares iBonds Dec 2030 Term Treasury ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:IBTK
Inception Date
7/14/2020
Fund Manager
James Mauro, Scott Radell
Web
N/A

Fund Focus

Asset Class
Fixed Income
Benchmark
ICE 2030 Maturity US Treasury Index (USD)
Category
U.S. Government
Focus
Treasury
Development Level
Developed Markets
Region
North America
Number of Holdings
16

Fund Statistics

Assets Under Management
$162.38 million
Average Daily Volume
$0.00
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
N/A
Short Interest
10,800 shs

Miscellaneous

Beta
0.20
Creation Unit
50,000
Creation Fee
$125.00
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

iShares iBonds Dec 2030 Term Treasury ETF Expenses

TypeIBTKTreasury ETFsFixed Income ETFsNASDAQ ETFsAll ETFs
Management Fee0.07%0.27%0.32%0.47%0.51%
Other Expenses0.00%0.35%0.27%0.29%0.57%
Total Expense0.07%0.36%0.39%0.56%0.69%
Fee Waiver0.00%-0.32%-0.24%-0.21%-0.57%
Net Expense0.07%0.33%0.35%0.52%0.57%

iShares iBonds Dec 2030 Term Treasury ETF (IBTK) Holdings

Top 10 IBTK Holdings

  • TREASURY NOTE - 0.88 2030-11-15
    Holding Weight: 19.90%
  • US TREASURY N/B - 0.63 2030-08-15
    Holding Weight: 17.56%
  • TREASURY NOTE - 0.63 2030-05-15
    Holding Weight: 13.06%
  • TREASURY NOTE - 1.5 2030-02-15
    Holding Weight: 11.08%
  • TREASURY NOTE - 4.0 2030-02-28
    Holding Weight: 10.94%
  • TREASURY NOTE - 3.5 2030-01-31
    Holding Weight: 7.33%
  • TREASURY NOTE - 3.5 2030-04-30
    Holding Weight: 5.81%
  • TREASURY NOTE (2OLD) - 3.75 2030-05-31
    Holding Weight: 5.76%
  • TREASURY NOTE - 3.63 2030-03-31
    Holding Weight: 4.54%
  • TREASURY NOTE (OLD) - 3.75 2030-06-30
    Holding Weight: 3.45%














IBTK ETF - Frequently Asked Questions

How have IBTK shares performed in 2023?

iShares iBonds Dec 2030 Term Treasury ETF's stock was trading at $19.5450 at the beginning of the year. Since then, IBTK shares have decreased by 1.3% and is now trading at $19.30.
View the best growth stocks for 2023 here
.

How often does iShares iBonds Dec 2030 Term Treasury ETF pay dividends? What is the dividend yield for iShares iBonds Dec 2030 Term Treasury ETF?

iShares iBonds Dec 2030 Term Treasury ETF declared a monthly dividend on Tuesday, October 31st. Stockholders of record on Thursday, November 2nd will be given a dividend of $0.062 per share on Tuesday, November 7th. This represents a $0.74 annualized dividend and a dividend yield of 3.85%. The ex-dividend date of this dividend is Wednesday, November 1st. This is an increase from the stock's previous monthly dividend of $0.04.
Read our dividend analysis for IBTK
.

What does IBTK invest in?

iShares iBonds Dec 2030 Term Treasury ETF is a fixed income fund issued by iShares. IBTK focuses on treasury investments and follows the ICE 2030 Maturity US Treasury Index (USD). The fund's investments total to approximately $162.38 million assets under management.

What is the management fee for iShares iBonds Dec 2030 Term Treasury ETF?

iShares iBonds Dec 2030 Term Treasury ETF's management fee is 0.07% and has no other recorded expenses or fee waivers. The net expense ratio for IBTK is 0.07%.

Who are iShares iBonds Dec 2030 Term Treasury ETF's major shareholders?

iShares iBonds Dec 2030 Term Treasury ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (11.24%) and Atlantic Private Wealth LLC (0.59%).

How do I buy shares of iShares iBonds Dec 2030 Term Treasury ETF?

Shares of IBTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:IBTK) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -